What is the most recent earnings date for HZNP stock?
HORIZON THERAPEUTICS PLC (HZNP) last reported earnings on 8/8/2023.
NASDAQ:HZNP • IE00BQPVQZ61
Past quarterly earnings results for HORIZON THERAPEUTICS PLC (HZNP), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2023 | 1.20 | 1.05 | 13.95% | 12.15% | 944.959M | 885.04M | 6.77% | 7.82% |
| Q1 2023 | 0.83 | 1.14 | -27.35% | -38.06% | 832.059M | 920.33M | -9.59% | -6.01% |
| Q4 2022 | 1.21 | 1.11 | 8.82% | -14.18% | 942.029M | 941.38M | 0.07% | -7.14% |
| Q3 2022 | 1.25 | 1.03 | 21.50% | -28.57% | 925.359M | 905.78M | 2.16% | -10.77% |
| Q2 2022 | 1.07 | 1.37 | -21.80% | -33.95% | 876.411M | 957.55M | -8.47% | 5.27% |
| Q1 2022 | 1.34 | 1.16 | 15.18% | 4,366.67% | 885.245M | 883.71M | 0.17% | 158.54% |
| Q4 2021 | 1.41 | 1.37 | 2.75% | 10.16% | 1.014B | 1.016B | -0.15% | 36.11% |
| Q3 2021 | 1.75 | 1.57 | 11.65% | 0.57% | 1.037B | 997.3M | 3.98% | 62.95% |
| Q2 2021 | 1.62 | 0.90 | 80.18% | 305.00% | 832.548M | 711.66M | 16.99% | 79.89% |
| Q1 2021 | 0.03 | 0.05 | -38.26% | -92.50% | 342.4M | 332.81M | 2.88% | -3.79% |
| Q4 2020 | 1.28 | 1.08 | 18.26% | - | 745.3M | 707.41M | 5.36% | - |
| Q3 2020 | 1.74 | 0.99 | 76.31% | - | 636.4M | 535.58M | 18.82% | - |
| Q2 2020 | 0.40 | 0.36 | 9.95% | - | 462.8M | 339.1M | 36.48% | - |
| Q1 2020 | 0.40 | 0.22 | 84.98% | - | 355.9M | 293.64M | 21.20% | - |
Notes
HORIZON THERAPEUTICS PLC (HZNP) last reported earnings on 8/8/2023.
HORIZON THERAPEUTICS PLC (HZNP) beat EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, HORIZON THERAPEUTICS PLC (HZNP) has beaten EPS estimates in 3 out of 4 releases.